| Literature DB >> 22326572 |
Dirk De Ruysscher1, M Mark Lodge, Bleddyn Jones, Michael Brada, Alastair Munro, Thomas Jefferson, Madelon Pijls-Johannesma.
Abstract
Although proton therapy has been used for many decades because of their superior dose distribution over photons and reduced integral dose, their clinical implementation is still controversial. We updated a systematic review of charged particle therapy. Although still no randomised trials were identified, the field is moving quickly and we therefore also formulated ways to move forward. In our view, the aim should be to build enough proton therapy facilities with interest in research to further improve the treatment and to run the needed clinical trials.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22326572 DOI: 10.1016/j.radonc.2012.01.003
Source DB: PubMed Journal: Radiother Oncol ISSN: 0167-8140 Impact factor: 6.280